Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682900 · ClinicalTrials.gov registry record · NA
Expanding the Click City Tobacco Prevention Program to Include E-cigarettes and Other Novel Tobacco Products
A NA study, sponsored by Oregon Research Behavioral Intervention Strategies.
- Completed
- Registry status
- NA
- Development phase
- 2,673
- Enrollment target
NCT03682900: Completed NA study, sponsored by Oregon Research Behavioral Intervention Strategies.
NCT03682900 is a NA study that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 2,673 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03682900, a NA study, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,673 participants
- Enrollment target
Study Summary
The goal of this study is to modify a smoking prevention program for 5th and 6th grade students to also target vaping e-cigarettes. Aims were to modify the program along with associated materials and to conduct a trial with 5th grade students in the school setting to see how well the updated program worked. Students either participated in the four-week computer based program or continued with their usual tobacco prevention curriculum. This study showed that students who received the computer program reduced their intentions and willingness to use e-cigarettes or smoke in the future more than did students who used their usual tobacco curriculum.
Primary Outcome
Measured by two items, assessing the student's intentions regarding vaping e-cigarettes as a teen or as a grown-up. Responses were on a five-point scale ranging from "definitely not" (1) to "definitely will" (5). The scale was created by summing the two items with potential range from 2 to 10. A higher score means a worse outcome.
Interventions
- OTHER Click City®: Tobacco
- OTHER Usual Tobacco Curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,673 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03682900 record still lists
NCT03682900 is an interventional study that assigns participants to a tested intervention. Its 2,673 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% higher).
The record links to 0 conditions, and to 2 interventions - of which Click City®: Tobacco is the first listed.
NCT03682900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03682900 about?
NCT03682900 is a clinical study titled "Expanding the Click City Tobacco Prevention Program to Include E-cigarettes and Other Novel Tobacco Products". The goal of this study is to modify a smoking prevention program for 5th and 6th grade students to also target vaping e-cigarettes. Aims were to modify the program along with associated materials and to conduct a trial with 5th grade students in the school setting to see how well the updated program...
What is the current status of trial NCT03682900?
This trial is currently completed. It is a NA study. The enrollment target is 2,673 participants. The study started on 2019-10-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03682900?
The interventions under investigation include: Click City®: Tobacco (OTHER), Usual Tobacco Curriculum (OTHER).
Who is sponsoring clinical trial NCT03682900?
This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03682900's enrollment target sits among peer trials
2,673 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI